Suppr超能文献

视神经炎:一项南非基于医院的前瞻性研究方案。

Optic neuritis: A South African hospital-based prospective study protocol.

机构信息

Division of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa.

Division of Neurology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

PLoS One. 2022 Jun 10;17(6):e0269514. doi: 10.1371/journal.pone.0269514. eCollection 2022.

Abstract

BACKGROUND

Optic neuritis is a relatively common disease with an estimated lifetime risk of 0.6 per 1000; the estimated prevalence is 1-5 per 100 000/year. It occurs because of inflammation of the optic nerve from a variety of causes. The diagnosis of the disorder is established clinically and current literature is predominantly based on white patients from high-income countries. Optic neuritis presents differently in black patients compared to white patients. This study aims to assess the presentation and outcome of optic neuritis patients in a South African setting.

METHODS

This is a prospective, hospital-based cohort study that will enrol patients with optic neuritis presenting to either the neurology department at Chris Hani Baragwanath Academic Hospital or the ophthalmology department at St John Eye Hospital, both in Johannesburg, South Africa. The specific aetiologies, clinical presentation and radiological findings will be studied, and the patient's course over one year will be documented in three-monthly follow-up visits. A specific group of patients with Neuromyelitis Optica Spectrum Disorders (NMOSD) and Myelin Oligodendrocyte Glycoprotein Associated Disorders (MOGAD) optic neuritis will be followed up for 5 years at yearly intervals.

DISCUSSION

This study represents one of the few cohort studies in Sub-Saharan Africa that seeks to investigate optic neuritis. Our hope is that it will lead to better insights regarding the presentation, course and outcome of this condition. We will also analyse the data with a view of developing a predictive model for good visual outcome.

摘要

背景

视神经炎是一种相对常见的疾病,估计终生风险为每 1000 人中 0.6 人;估计患病率为每年每 10 万人中有 1-5 人。它是由于各种原因引起的视神经炎症引起的。该疾病的诊断是临床确立的,目前的文献主要基于来自高收入国家的白种人。视神经炎在黑种人和白人患者中的表现不同。本研究旨在评估南非环境中视神经炎患者的表现和结局。

方法

这是一项前瞻性、基于医院的队列研究,将招募在南非约翰内斯堡克里斯·哈尼·巴哈格万萨医院的神经科或圣约翰眼科医院的眼科就诊的视神经炎患者。将研究特定的病因、临床表现和放射学发现,并在每三个月的随访中记录患者在一年内的病程。一组特定的视神经脊髓炎谱系疾病(NMOSD)和髓鞘少突胶质细胞糖蛋白相关疾病(MOGAD)视神经炎患者将在每年一次的 5 年随访中进行随访。

讨论

本研究代表了撒哈拉以南非洲少数几项旨在研究视神经炎的队列研究之一。我们希望它能更好地了解这种疾病的表现、病程和结局。我们还将分析数据,以期建立一个良好视觉结局的预测模型。

相似文献

1
Optic neuritis: A South African hospital-based prospective study protocol.
PLoS One. 2022 Jun 10;17(6):e0269514. doi: 10.1371/journal.pone.0269514. eCollection 2022.
3
Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
Eur J Ophthalmol. 2019 Mar;29(2):257-261. doi: 10.1177/1120672118784797. Epub 2018 Jul 4.
6
[The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis].
Zhonghua Yan Ke Za Zhi. 2017 Nov 11;53(11):874-877. doi: 10.3760/cma.j.issn.0412-4081.2017.11.016.
7
Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
Mult Scler Relat Disord. 2021 Nov;56:103222. doi: 10.1016/j.msard.2021.103222. Epub 2021 Aug 24.
8
Treatment outcomes of first-ever episode of severe optic neuritis.
Mult Scler Relat Disord. 2022 Oct;66:104020. doi: 10.1016/j.msard.2022.104020. Epub 2022 Jul 2.
9
Optic neuritis: current challenges in diagnosis and management.
Curr Opin Neurol. 2023 Feb 1;36(1):10-18. doi: 10.1097/WCO.0000000000001128. Epub 2022 Dec 5.

本文引用的文献

1
Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders.
Neurol Neuroimmunol Neuroinflamm. 2021 Dec 26;9(2). doi: 10.1212/NXI.0000000000001126. Print 2022 Mar.
2
Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review.
Neurol Neuroimmunol Neuroinflamm. 2021 Oct 18;8(6). doi: 10.1212/NXI.0000000000001089. Print 2021 Nov.
3
Retinal Optical Coherence Tomography in Neuromyelitis Optica.
Neurol Neuroimmunol Neuroinflamm. 2021 Sep 15;8(6). doi: 10.1212/NXI.0000000000001068. Print 2021 Nov.
4
Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Lancet Neurol. 2021 Sep;20(9):762-772. doi: 10.1016/S1474-4422(21)00218-0.
5
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Neurol Neuroimmunol Neuroinflamm. 2019 May 21;6(4):e572. doi: 10.1212/NXI.0000000000000572. eCollection 2019 Jul.
6
Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes.
Biomedicines. 2019 Jun 12;7(2):42. doi: 10.3390/biomedicines7020042.
7
The REDCap consortium: Building an international community of software platform partners.
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
8
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.
Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.
9
Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.
JAMA Neurol. 2018 Jan 1;75(1):65-71. doi: 10.1001/jamaneurol.2017.3196.
10
A population-based prospective study of optic neuritis.
Mult Scler. 2017 Dec;23(14):1893-1901. doi: 10.1177/1352458517734070. Epub 2017 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验